Verici Dx (LON:VRCI) Shares Down 4.3% – Time to Sell?

Verici Dx plc (LON:VRCI)’s share price traded down 4.3% on Thursday . The stock traded as low as GBX 0.55 and last traded at GBX 0.55. 204,178 shares changed hands during trading, a decline of 86% from the average session volume of 1,441,759 shares. The stock had previously closed at GBX 0.58.

Verici Dx Stock Performance

The company has a debt-to-equity ratio of 11.36, a quick ratio of 8.49 and a current ratio of 0.91. The stock has a market cap of £8.32 million, a P/E ratio of -0.19 and a beta of 1.52. The business’s 50-day moving average price is GBX 0.65 and its 200-day moving average price is GBX 0.70.

About Verici Dx

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.